Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 6835-3p (miR-6835-3p) is a small non-coding RNA molecule involved in the post-transcriptional regulation of gene expression. It directly targets the mRNA of adiponectin receptor 1 (AdipoR1) in pancreatic islet cells, suppressing its expression and thereby inhibiting glucose-stimulated insulin secretion. Experimental data indicate that inhibition of miR-6835-3p can promote insulin release, highlighting a possible therapeutic strategy for improving beta cell function in type 2 diabetes mellitus.
Inhibitors of miR-6835-3p may relieve repression of AdipoR1, thereby promoting glucose-stimulated insulin secretion. Mimics of miR-6835-3p suppress AdipoR1 expression, inhibiting insulin secretion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6835-3p (miR-6835-3p).